Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

At Texas A&M University, one research lab is changing the game of droplet microfluidics, a technique that involves conducting ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

As the government continues its search for a new Drugs Controller General of India (DCGI), it has decided to extend the ...

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

Prince Harry admitted some time ago to using drugs. According to the law, such an admission could block his chances of ...

Liability and injury: Changes to the existing liability protections for certain vaccine makers and modifications to the list ...

This piece is part of a series that dives deeper into the most prevalent themes of this year’s iteration of our flagship research piece, Charting Disruption. Click to read.

Shares of Ionis Pharmaceuticals (NASDAQ:IONS) climbed 7% today after the company announced that regulatory agencies in the ...

In September, a judge ruled that his US visa would stay private – but a federal judge has now ordered that Harry and Heritage ...

Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the ...